TP53 and cervical cancer: Considering the recent findings that E6AP promotes thedeacetylation and degradation of HDAC6-mediated tumor suppressors [10], combined with the experimental findings, we hypothesize thatthere might be a cross-talk mechanism for the ubiquitination and acetylation of p53 inHPV-positive cervical cancer.